aluates Reports

$ 0.0

Automative

Global Biopharmaceutical Process Development Services Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-3T13622

Global Biopharmaceutical Process Development Services Market Research Report 2023

BUY CHAPTERS

Global Biopharmaceutical Process Development Services Market Research Report 2025

Code: QYRE-Auto-3T13622

Report

March 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck Millipore

Cytiva

Coriolis Pharma

Lonza

Avantor

KBI Biopharma

Rommelag

FyoniBio GmbH

Rentschler Biopharma SE

BioPharma Services

Premas Biotech

Kemwell Biopharma

Pace Life Sciences

GenIbet

Biopharmaceutical Process Development Services Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical Process Development Services Market

The global market for Biopharmaceutical Process Development Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Process Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Process Development Services.

The Biopharmaceutical Process Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical Process Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical Process Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biopharmaceutical Process Development Services Market Report

Report Metric	Details
Report Name	Biopharmaceutical Process Development Services Market
CAGR	5%
Segment by Type	Cell Culture Upstream Process Development Downstream Process Development
Segment by Application	Small and Medium Enterprises Large Enterprises
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck Millipore, Cytiva, Coriolis Pharma, Lonza, Premas Biotech, Kemwell Biopharma, Avantor, Pace Life Sciences, KBI Biopharma, Rommelag, FyoniBio, Rentschler Biopharma SE, BioPharma Services, GenIbet
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical Process Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceutical Process Development Services Market report?

Ans: The main players in the Biopharmaceutical Process Development Services Market are Merck Millipore, Cytiva, Coriolis Pharma, Lonza, Premas Biotech, Kemwell Biopharma, Avantor, Pace Life Sciences, KBI Biopharma, Rommelag, FyoniBio, Rentschler Biopharma SE, BioPharma Services, GenIbet

What are the Application segmentation covered in the Biopharmaceutical Process Development Services Market report?

Ans: The Applications covered in the Biopharmaceutical Process Development Services Market report are Small and Medium Enterprises, Large Enterprises

What are the Type segmentation covered in the Biopharmaceutical Process Development Services Market report?

Ans: The Types covered in the Biopharmaceutical Process Development Services Market report are Cell Culture, Upstream Process Development, Downstream Process Development

Recommended Reports

Process Development

Pharmaceutical Services

Biologics & Biopharma

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical Process Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cell Culture

1.2.3 Upstream Process Development

1.2.4 Downstream Process Development

1.3 Market by Application

1.3.1 Global Biopharmaceutical Process Development Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Small and Medium Enterprises

1.3.3 Large Enterprises

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical Process Development Services Market Perspective (2020-2031)

2.2 Global Biopharmaceutical Process Development Services Growth Trends by Region

2.2.1 Global Biopharmaceutical Process Development Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biopharmaceutical Process Development Services Historic Market Size by Region (2020-2025)

2.2.3 Biopharmaceutical Process Development Services Forecasted Market Size by Region (2026-2031)

2.3 Biopharmaceutical Process Development Services Market Dynamics

2.3.1 Biopharmaceutical Process Development Services Industry Trends

2.3.2 Biopharmaceutical Process Development Services Market Drivers

2.3.3 Biopharmaceutical Process Development Services Market Challenges

2.3.4 Biopharmaceutical Process Development Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical Process Development Services Players by Revenue

3.1.1 Global Top Biopharmaceutical Process Development Services Players by Revenue (2020-2025)

3.1.2 Global Biopharmaceutical Process Development Services Revenue Market Share by Players (2020-2025)

3.2 Global Biopharmaceutical Process Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biopharmaceutical Process Development Services Revenue

3.4 Global Biopharmaceutical Process Development Services Market Concentration Ratio

3.4.1 Global Biopharmaceutical Process Development Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Process Development Services Revenue in 2024

3.5 Global Key Players of Biopharmaceutical Process Development Services Head office and Area Served

3.6 Global Key Players of Biopharmaceutical Process Development Services, Product and Application

3.7 Global Key Players of Biopharmaceutical Process Development Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical Process Development Services Breakdown Data by Type

4.1 Global Biopharmaceutical Process Development Services Historic Market Size by Type (2020-2025)

4.2 Global Biopharmaceutical Process Development Services Forecasted Market Size by Type (2026-2031)

5 Biopharmaceutical Process Development Services Breakdown Data by Application

5.1 Global Biopharmaceutical Process Development Services Historic Market Size by Application (2020-2025)

5.2 Global Biopharmaceutical Process Development Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biopharmaceutical Process Development Services Market Size (2020-2031)

6.2 North America Biopharmaceutical Process Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biopharmaceutical Process Development Services Market Size by Country (2020-2025)

6.4 North America Biopharmaceutical Process Development Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical Process Development Services Market Size (2020-2031)

7.2 Europe Biopharmaceutical Process Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biopharmaceutical Process Development Services Market Size by Country (2020-2025)

7.4 Europe Biopharmaceutical Process Development Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical Process Development Services Market Size (2020-2031)

8.2 Asia-Pacific Biopharmaceutical Process Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biopharmaceutical Process Development Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Biopharmaceutical Process Development Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical Process Development Services Market Size (2020-2031)

9.2 Latin America Biopharmaceutical Process Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biopharmaceutical Process Development Services Market Size by Country (2020-2025)

9.4 Latin America Biopharmaceutical Process Development Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical Process Development Services Market Size (2020-2031)

10.2 Middle East & Africa Biopharmaceutical Process Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck Millipore

11.1.1 Merck Millipore Company Details

11.1.2 Merck Millipore Business Overview

11.1.3 Merck Millipore Biopharmaceutical Process Development Services Introduction

11.1.4 Merck Millipore Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.1.5 Merck Millipore Recent Development

11.2 Cytiva

11.2.1 Cytiva Company Details

11.2.2 Cytiva Business Overview

11.2.3 Cytiva Biopharmaceutical Process Development Services Introduction

11.2.4 Cytiva Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.2.5 Cytiva Recent Development

11.3 Coriolis Pharma

11.3.1 Coriolis Pharma Company Details

11.3.2 Coriolis Pharma Business Overview

11.3.3 Coriolis Pharma Biopharmaceutical Process Development Services Introduction

11.3.4 Coriolis Pharma Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.3.5 Coriolis Pharma Recent Development

11.4 Lonza

11.4.1 Lonza Company Details

11.4.2 Lonza Business Overview

11.4.3 Lonza Biopharmaceutical Process Development Services Introduction

11.4.4 Lonza Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.4.5 Lonza Recent Development

11.5 Premas Biotech

11.5.1 Premas Biotech Company Details

11.5.2 Premas Biotech Business Overview

11.5.3 Premas Biotech Biopharmaceutical Process Development Services Introduction

11.5.4 Premas Biotech Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.5.5 Premas Biotech Recent Development

11.6 Kemwell Biopharma

11.6.1 Kemwell Biopharma Company Details

11.6.2 Kemwell Biopharma Business Overview

11.6.3 Kemwell Biopharma Biopharmaceutical Process Development Services Introduction

11.6.4 Kemwell Biopharma Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.6.5 Kemwell Biopharma Recent Development

11.7 Avantor

11.7.1 Avantor Company Details

11.7.2 Avantor Business Overview

11.7.3 Avantor Biopharmaceutical Process Development Services Introduction

11.7.4 Avantor Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.7.5 Avantor Recent Development

11.8 Pace Life Sciences

11.8.1 Pace Life Sciences Company Details

11.8.2 Pace Life Sciences Business Overview

11.8.3 Pace Life Sciences Biopharmaceutical Process Development Services Introduction

11.8.4 Pace Life Sciences Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.8.5 Pace Life Sciences Recent Development

11.9 KBI Biopharma

11.9.1 KBI Biopharma Company Details

11.9.2 KBI Biopharma Business Overview

11.9.3 KBI Biopharma Biopharmaceutical Process Development Services Introduction

11.9.4 KBI Biopharma Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.9.5 KBI Biopharma Recent Development

11.10 Rommelag

11.10.1 Rommelag Company Details

11.10.2 Rommelag Business Overview

11.10.3 Rommelag Biopharmaceutical Process Development Services Introduction

11.10.4 Rommelag Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.10.5 Rommelag Recent Development

11.11 FyoniBio

11.11.1 FyoniBio Company Details

11.11.2 FyoniBio Business Overview

11.11.3 FyoniBio Biopharmaceutical Process Development Services Introduction

11.11.4 FyoniBio Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.11.5 FyoniBio Recent Development

11.12 Rentschler Biopharma SE

11.12.1 Rentschler Biopharma SE Company Details

11.12.2 Rentschler Biopharma SE Business Overview

11.12.3 Rentschler Biopharma SE Biopharmaceutical Process Development Services Introduction

11.12.4 Rentschler Biopharma SE Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.12.5 Rentschler Biopharma SE Recent Development

11.13 BioPharma Services

11.13.1 BioPharma Services Company Details

11.13.2 BioPharma Services Business Overview

11.13.3 BioPharma Services Biopharmaceutical Process Development Services Introduction

11.13.4 BioPharma Services Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.13.5 BioPharma Services Recent Development

11.14 GenIbet

11.14.1 GenIbet Company Details

11.14.2 GenIbet Business Overview

11.14.3 GenIbet Biopharmaceutical Process Development Services Introduction

11.14.4 GenIbet Revenue in Biopharmaceutical Process Development Services Business (2020-2025)

11.14.5 GenIbet Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck Millipore

Cytiva

Coriolis Pharma

Lonza

Avantor

KBI Biopharma

Rommelag

FyoniBio GmbH

Rentschler Biopharma SE

BioPharma Services

Premas Biotech

Kemwell Biopharma

Pace Life Sciences

GenIbet

List of Tables

Table 1. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cell Culture

Table 3. Key Players of Upstream Process Development

Table 4. Key Players of Downstream Process Development

Table 5. Global Biopharmaceutical Process Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Biopharmaceutical Process Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Biopharmaceutical Process Development Services Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Biopharmaceutical Process Development Services Market Share by Region (2020-2025)

Table 9. Global Biopharmaceutical Process Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Biopharmaceutical Process Development Services Market Share by Region (2026-2031)

Table 11. Biopharmaceutical Process Development Services Market Trends

Table 12. Biopharmaceutical Process Development Services Market Drivers

Table 13. Biopharmaceutical Process Development Services Market Challenges

Table 14. Biopharmaceutical Process Development Services Market Restraints

Table 15. Global Biopharmaceutical Process Development Services Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Biopharmaceutical Process Development Services Market Share by Players (2020-2025)

Table 17. Global Top Biopharmaceutical Process Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Process Development Services as of 2024)

Table 18. Ranking of Global Top Biopharmaceutical Process Development Services Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Biopharmaceutical Process Development Services Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Biopharmaceutical Process Development Services, Headquarters and Area Served

Table 21. Global Key Players of Biopharmaceutical Process Development Services, Product and Application

Table 22. Global Key Players of Biopharmaceutical Process Development Services, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Biopharmaceutical Process Development Services Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2020-2025)

Table 26. Global Biopharmaceutical Process Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2026-2031)

Table 28. Global Biopharmaceutical Process Development Services Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2020-2025)

Table 30. Global Biopharmaceutical Process Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2026-2031)

Table 32. North America Biopharmaceutical Process Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Biopharmaceutical Process Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Biopharmaceutical Process Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Biopharmaceutical Process Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Biopharmaceutical Process Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Biopharmaceutical Process Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Biopharmaceutical Process Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Biopharmaceutical Process Development Services Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Biopharmaceutical Process Development Services Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Biopharmaceutical Process Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Biopharmaceutical Process Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Biopharmaceutical Process Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Biopharmaceutical Process Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 47. Merck Millipore Company Details

Table 48. Merck Millipore Business Overview

Table 49. Merck Millipore Biopharmaceutical Process Development Services Product

Table 50. Merck Millipore Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 51. Merck Millipore Recent Development

Table 52. Cytiva Company Details

Table 53. Cytiva Business Overview

Table 54. Cytiva Biopharmaceutical Process Development Services Product

Table 55. Cytiva Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 56. Cytiva Recent Development

Table 57. Coriolis Pharma Company Details

Table 58. Coriolis Pharma Business Overview

Table 59. Coriolis Pharma Biopharmaceutical Process Development Services Product

Table 60. Coriolis Pharma Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 61. Coriolis Pharma Recent Development

Table 62. Lonza Company Details

Table 63. Lonza Business Overview

Table 64. Lonza Biopharmaceutical Process Development Services Product

Table 65. Lonza Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 66. Lonza Recent Development

Table 67. Premas Biotech Company Details

Table 68. Premas Biotech Business Overview

Table 69. Premas Biotech Biopharmaceutical Process Development Services Product

Table 70. Premas Biotech Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 71. Premas Biotech Recent Development

Table 72. Kemwell Biopharma Company Details

Table 73. Kemwell Biopharma Business Overview

Table 74. Kemwell Biopharma Biopharmaceutical Process Development Services Product

Table 75. Kemwell Biopharma Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 76. Kemwell Biopharma Recent Development

Table 77. Avantor Company Details

Table 78. Avantor Business Overview

Table 79. Avantor Biopharmaceutical Process Development Services Product

Table 80. Avantor Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 81. Avantor Recent Development

Table 82. Pace Life Sciences Company Details

Table 83. Pace Life Sciences Business Overview

Table 84. Pace Life Sciences Biopharmaceutical Process Development Services Product

Table 85. Pace Life Sciences Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 86. Pace Life Sciences Recent Development

Table 87. KBI Biopharma Company Details

Table 88. KBI Biopharma Business Overview

Table 89. KBI Biopharma Biopharmaceutical Process Development Services Product

Table 90. KBI Biopharma Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 91. KBI Biopharma Recent Development

Table 92. Rommelag Company Details

Table 93. Rommelag Business Overview

Table 94. Rommelag Biopharmaceutical Process Development Services Product

Table 95. Rommelag Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 96. Rommelag Recent Development

Table 97. FyoniBio Company Details

Table 98. FyoniBio Business Overview

Table 99. FyoniBio Biopharmaceutical Process Development Services Product

Table 100. FyoniBio Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 101. FyoniBio Recent Development

Table 102. Rentschler Biopharma SE Company Details

Table 103. Rentschler Biopharma SE Business Overview

Table 104. Rentschler Biopharma SE Biopharmaceutical Process Development Services Product

Table 105. Rentschler Biopharma SE Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 106. Rentschler Biopharma SE Recent Development

Table 107. BioPharma Services Company Details

Table 108. BioPharma Services Business Overview

Table 109. BioPharma Services Biopharmaceutical Process Development Services Product

Table 110. BioPharma Services Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 111. BioPharma Services Recent Development

Table 112. GenIbet Company Details

Table 113. GenIbet Business Overview

Table 114. GenIbet Biopharmaceutical Process Development Services Product

Table 115. GenIbet Revenue in Biopharmaceutical Process Development Services Business (2020-2025) & (US$ Million)

Table 116. GenIbet Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Biopharmaceutical Process Development Services Picture

Figure 2. Global Biopharmaceutical Process Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biopharmaceutical Process Development Services Market Share by Type: 2024 VS 2031

Figure 4. Cell Culture Features

Figure 5. Upstream Process Development Features

Figure 6. Downstream Process Development Features

Figure 7. Global Biopharmaceutical Process Development Services Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Biopharmaceutical Process Development Services Market Share by Application: 2024 VS 2031

Figure 9. Small and Medium Enterprises Case Studies

Figure 10. Large Enterprises Case Studies

Figure 11. Biopharmaceutical Process Development Services Report Years Considered

Figure 12. Global Biopharmaceutical Process Development Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Biopharmaceutical Process Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Biopharmaceutical Process Development Services Market Share by Region: 2024 VS 2031

Figure 15. Global Biopharmaceutical Process Development Services Market Share by Players in 2024

Figure 16. Global Top Biopharmaceutical Process Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Process Development Services as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical Process Development Services Revenue in 2024

Figure 18. North America Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Biopharmaceutical Process Development Services Market Share by Country (2020-2031)

Figure 20. United States Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Biopharmaceutical Process Development Services Market Share by Country (2020-2031)

Figure 24. Germany Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Biopharmaceutical Process Development Services Market Share by Region (2020-2031)

Figure 32. China Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Biopharmaceutical Process Development Services Market Share by Country (2020-2031)

Figure 40. Mexico Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Biopharmaceutical Process Development Services Market Share by Country (2020-2031)

Figure 44. Turkey Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Biopharmaceutical Process Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Merck Millipore Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 48. Cytiva Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 49. Coriolis Pharma Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 50. Lonza Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 51. Premas Biotech Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 52. Kemwell Biopharma Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 53. Avantor Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 54. Pace Life Sciences Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 55. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 56. Rommelag Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 57. FyoniBio Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 58. Rentschler Biopharma SE Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 59. BioPharma Services Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 60. GenIbet Revenue Growth Rate in Biopharmaceutical Process Development Services Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global BioPharma Service Market Research Report 2024

Biopharmaceuticals Contract Manufacturing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Preclinical Drug Development Services Market Research Report 2025

Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

New Drug Research and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical Cleanroom Market Research Report 2025

Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Liquid Handling Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Analysis Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biomedical Testing Services Market Research Report 2025

Global Biomedical Analysis Services Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Global Drug Stability Testing Services Market Research Report 2025

Global Pharma Contract Service Market Research Report 2025

Global Biopharm Processing and Packaging Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Global Biopharmaceutical Processing Consumables Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions